These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 1091827

  • 1. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H.
    Med Klin; 1975 Mar 07; 70(10):409-15. PubMed ID: 1091827
    [No Abstract] [Full Text] [Related]

  • 2. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease.
    Normand IC.
    Bull Physiopathol Respir (Nancy); 1973 Mar 07; 9(6):1473-94. PubMed ID: 4602246
    [No Abstract] [Full Text] [Related]

  • 3. Respiratory distress syndrome in the tiny baby.
    Fawcett WA, Gluck L.
    Clin Perinatol; 1977 Sep 07; 4(2):411-23. PubMed ID: 332436
    [No Abstract] [Full Text] [Related]

  • 4. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
    Göcke H, Bienengräber A.
    Zentralbl Chir; 1974 Aug 23; 99(34):1057-61. PubMed ID: 4613061
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
    Puchkov GF, Iazvinskiĭ II.
    Sov Med; 1975 Aug 23; (8):62. PubMed ID: 1105810
    [No Abstract] [Full Text] [Related]

  • 9. The first expiration: role of pulmonary surfactant.
    Chernick V.
    Semin Perinatol; 1977 Oct 23; 1(4):351-5. PubMed ID: 382368
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Study of fetal alveolar surfactant: possibility of induction].
    Bracaglia R, Bellati U, Serri F, Garzetti GG.
    Clin Ter; 1979 Dec 31; 91(6):593-606. PubMed ID: 44494
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May 31; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

  • 16. [For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
    Storme L, Truffert P, Rakza T, Lequien P.
    Arch Pediatr; 1999 May 31; 6(5):549-55. PubMed ID: 10370813
    [Abstract] [Full Text] [Related]

  • 17. Adrenal gland structure and the development of hyaline membrane disease.
    Naeye RL, Harcke HT, Blanc WA.
    Pediatrics; 1971 Apr 31; 47(4):650-7. PubMed ID: 5109055
    [No Abstract] [Full Text] [Related]

  • 18. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB.
    Semin Perinatol; 1994 Feb 31; 18(1):19-22. PubMed ID: 8209282
    [No Abstract] [Full Text] [Related]

  • 19. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC, Howie RN.
    Pediatrics; 1972 Oct 31; 50(4):515-25. PubMed ID: 4561295
    [No Abstract] [Full Text] [Related]

  • 20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul 31; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.